Sumitomo Mitsui Trust Group
IRWD icon

Sumitomo Mitsui Trust Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,867
Closed -$168K – 1054
2024
Q3 		$168K Sell
40,867
-19,100
-32% -$103K ﹤0.01% 1046
2024
Q2 		$391K Buy
59,967
+4,100
+7% +$29K ﹤0.01% 989
2024
Q1 		$487K Buy
+55,867
New +$678K ﹤0.01% 1026
2023
Q4 		– Sell
-27,373
Closed -$264K – 1129
2023
Q3 		$264K Sell
27,373
-14,000
-34% -$137K ﹤0.01% 1097
2023
Q2 		$440K Buy
+41,373
New +$445K ﹤0.01% 1069
2023
Q1 		– Sell
-10,868
Closed -$135K – 1169
2022
Q4 		$135K Buy
+10,868
New +$123K ﹤0.01% 1172

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group's IRWD Position: Q4 2024 in Review

Sumitomo Mitsui Trust Group sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 40,867 shares — an estimated $168K sold.

Sumitomo Mitsui Trust Group first reported a position in IRWD in Q4 2022 and held it in 6 quarters. The position peaked at $487K in Q1 2024. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Sumitomo Mitsui Trust Group reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 40,867 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $168K.
  • Sumitomo Mitsui Trust Group first reported a position in Ironwood Pharmaceuticals in Q4 2022 and held it in 6 quarters.
  • Sumitomo Mitsui Trust Group's Ironwood Pharmaceuticals position peaked at $487K in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2024, filed 28 Jan 2025.